API Quality & Variability Issues

API Quality Variability Causing Batch Failures? Control Strategies for Consistent Raw Materials

Strategies for Managing API Quality Variability to Prevent Batch Failures In the pharmaceutical manufacturing environment, quality issues stemming from active pharmaceutical ingredients (APIs) can lead to significant batch failures, leading…

API stability failure during stability studies – regulatory impact assessment

Detecting an API stability failure usually begins with specific symptoms or signals observed during either routine stability testing or in-process evaluations. Common signs include:Click to read the full article.

Impurity profile drift detected during regulatory inspection – preventing batch rejection and recall

The first step in addressing impurity profile drift is recognizing the symptoms or signals that indicate a potential issue. In a typical manufacturing environment, several signs warrant immediate investigation:Click to…

Particle size variability impacts performance during incoming testing – root cause investigation framework

Awareness of symptoms or signals of potential particle size issues is crucial for timely intervention. Common indicators that may suggest particle size variability during incoming testing include:Click to read the…

API stability failure during deviation investigation – CAPA aligned to GMP expectations

Identifying signals of API stability failure is the first step in addressing potential deviations. Symptoms can manifest as unexpected results during stability testing or changes in physical characteristics of the…

API stability failure during supplier change – preventing batch rejection and recall

Identifying the early signals of instability in APIs is critical to taking prompt corrective actions. Symptoms may manifest as:Click to read the full article.

API assay variability exceeds trend limits during regulatory inspection – inspection questions regulators ask

Investigating API Assay Variability that Exceeds Trend Limits During Regulatory Inspections During a regulatory inspection, finding that API assay variability exceeds established trend limits can trigger significant concern. This situation…

Impurity profile drift detected during supplier change – inspection questions regulators ask

Identifying symptoms of impurity profile drift involves various signals from both the production floor and laboratory analyses. Key indicators may include:Click to read the full article.

Polymorphic form inconsistency during incoming testing – inspection questions regulators ask

Recognizing symptoms or signals of polymorphic form inconsistency is essential for timely resolution. These symptoms may manifest at various stages of the manufacturing process or within quality control (QC) testing.…

Particle size variability impacts performance during regulatory inspection – preventing batch rejection and recall

Symptoms of particle size variability can manifest in various forms during both the manufacturing and quality control processes. These signals may indicate underlying issues that require immediate attention to avoid…

Particle size variability impacts performance during deviation investigation – preventing batch rejection and recall

Identifying signals that reflect particle size variability is crucial for timely intervention. Symptoms can manifest as batch performance issues or quality complaints from the lab or production floor. Common indicators…

Residual solvent excursions during stability studies – regulatory impact assessment

The first step in managing residual solvent excursions is recognizing the symptoms or signals that indicate a potential quality issue during stability studies. Some common signs include:Click to read the…